EUCTR2013-001616-30-IT进行中（未招募）1 期
A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programme - ESTHER-2
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Subjects who participated in ESTHER-1 - trial 000004 (COS cycle 1) and failed to achieve an ongoing pregnancy may be included in this trial. Subjects failing to achieve an ongoing pregnancy in COS cycle 2 may be offered to start COS cycle 3 after ensuring that they are still compliant with the eligibility criteria. Continuation to COS cycle 3 is only an option until the required number of subjects have been included (approximately 200).
- •[COS controlled ovarian stimulation]
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 400
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Any clinically relevant changes to any of the eligibility criteria in the previous cycle(s)
研究者
相似试验
进行中（未招募）
1 期
A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programmeMedDRA version: 14.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersInfertilityEUCTR2013-001616-30-DKFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programmeMedDRA version: 16.0Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersInfertilityEUCTR2013-001616-30-BEFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programmeMedDRA version: 16.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersInfertilityEUCTR2013-001616-30-PLFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programmeMedDRA version: 16.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersInfertilityEUCTR2013-001616-30-CZFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A controlled, assessor-blind, parallel groups, multicentre, multinational trial evaluating the immunogenicity of FE 999049 in repeated cycles of controlled ovarian stimulation in women undergoing an assisted reproductive technology programmeMedDRA version: 14.1Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersInfertilityEUCTR2013-001616-30-GBFerring Pharmaceuticals A/S400